Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Trials
Buse, John B., Garber, Alan, Rosenstock, Julio, Schmidt, Wolfgang E., Brett, Jason H., Videbæk, Nicoline, Holst, Jens, Nauck, MichaelVolume:
96
Language:
english
Journal:
The Journal of Clinical Endocrinology & Metabolism
DOI:
10.1210/jc.2010-2822
Date:
June, 2011
File:
PDF, 705 KB
english, 2011